Covalon Technologies Ltd. (OTCMKTS:CVALF) shares decreased by 11.8% on Monday. The company has a market capitalization of $37.61 million and focuses on the development, manufacturing, and marketing of patent-protected medical products, with a strong emphasis on wound care, infection management, and surgical procedures. The company had revenue of $4.13 million for the quarter and a negative net margin of 44.56% and a negative return on equity of 31.23%. The stock’s 50-day moving average is $1.67 and its 200-day moving average is $1.73. Covalon Technologies sells its products under the Covalon brand in advanced wound care, vascular access, perioperative care, and urology categories.
Covalon Technologies Ltd. (OTCMKTS:CVALF) shares decreased by 11.8% on Monday. The stock traded as low as $1.50 and last traded at the same price. The company traded 6,200 shares during the session. The company has a market capitalization of $37.61 million, with a price-to-earnings ratio of -6.00 and a beta of -0.51. The stock’s 50-day moving average is $1.67 and its 200-day moving average is $1.73. Covalon Technologies last reported earnings on Wednesday, January 25th. For the quarter, the company had revenue of $4.13 million, with a negative net margin of 44.56% and a negative return on equity of 31.23%. Covalon Technologies develops, manufactures, and markets patent-protected medical products, focusing on wound care, infection management, and surgical procedures under the Covalon brand. Its product categories include advanced wound care, vascular access, perioperative care, and urology.
Don’t miss interesting posts on Famousbio
